Literature DB >> 3139717

Use of theophylline in the investigation of pseudothrombocytopenia induced by edetic acid (EDTA-2K).

O Ohnuma1, Y Shirata, K Miyazawa.   

Abstract

In automated cell counting of edetic acid (EDTA-2K) anticoagulated blood, thrombocytopenia is occasionally seen which bears no relation to any underlying disease. In this study a heparin and soluble theophylline mixture was used to measure accurately platelet numbers in patients with such pseudothrombocytopenia. In four normal volunteers, a theophylline concentration of more than 7 mg/ml produced no significant difference in platelet numbers between theophylline and heparin and EDTA-2K anticoagulated bloods. When blood treated with EDTA-2K was used in seven patients with pseudothrombocytopenia, falsely low platelet counts were observed in three patients immediately after sampling; in blood treated with theophylline, white cell and platelet counts remained unchanged for up to six hours after sampling. Microscopical examination of the EDTA-2K anticoagulated blood showed massive platelet clumping, but no aggregates were seen in theophylline anticoagulated blood. It is concluded that theophylline can be useful in the investigation of pseudothrombocytopenia when an automated cell counter is used.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3139717      PMCID: PMC1141628          DOI: 10.1136/jcp.41.8.915

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  13 in total

1.  Pseudothrombocytopenia due to agglutinins.

Authors:  W A Veenhoven; G S van der Schans; W Huiges; H E Metting-Scherphuis; M R Halie; H O Nieweg
Journal:  Am J Clin Pathol       Date:  1979-12       Impact factor: 2.493

2.  Spurious thrombocytopenia.

Authors:  C R Kjeldsberg; E J Hershgold
Journal:  JAMA       Date:  1974-02-11       Impact factor: 56.272

3.  Letter: Spurious thrombocytopenia.

Authors:  C Y Rhee
Journal:  JAMA       Date:  1974-05-27       Impact factor: 56.272

4.  Letter: Pseudothrombocytopenia.

Authors:  P L Cimo
Journal:  JAMA       Date:  1974-08-12       Impact factor: 56.272

5.  Evaluation of a semi-automated platelet-counting system.

Authors:  R M Rowan; C Fraser; J H Gray; G A McDonald
Journal:  J Clin Pathol       Date:  1977-04       Impact factor: 3.411

6.  Pseudothrombocytopenia caused by platelet agglutinins that are reactive in blood anticoagulated with chelating agents.

Authors:  O Onder; A Weinstein; L W Hoyer
Journal:  Blood       Date:  1980-08       Impact factor: 22.113

7.  Pseudothrombocytopenia: manifestation of a new type of platelet agglutinin.

Authors:  D P Shreiner; W R Bell
Journal:  Blood       Date:  1973-10       Impact factor: 22.113

8.  The effect of EDTA, cations, and various buffers on the morphology of erythrocyte membranes: an electron-microscopic study.

Authors:  L Pinteric; J F Manery; I H Chaudry; G Madapallimattam
Journal:  Blood       Date:  1975-05       Impact factor: 22.113

9.  Pseudothrombocytopenia. In vitro studies on the underlying mechanism.

Authors:  R Manthorpe; B Kofod; A Wiik; O Saxtrup; S E Svehag
Journal:  Scand J Haematol       Date:  1981-05

10.  Spurious leukocytosis and thrombocytopenia. A dual phenomenon caused by clumping of platelets in vitro.

Authors:  D L Solanki; B C Blackburn
Journal:  JAMA       Date:  1983-11-11       Impact factor: 56.272

View more
  2 in total

1.  Ethylenediaminetetraacetic Acid (EDTA) - dependent pseudothrombocytopenia: a case report.

Authors:  Izhar Shabnam; Chuphal D S; Joshi B C
Journal:  J Clin Diagn Res       Date:  2014-10-20

2.  Effective estimation of correct platelet counts in pseudothrombocytopenia using an alternative anticoagulant based on magnesium salt.

Authors:  Peter Schuff-Werner; Michael Steiner; Sebastian Fenger; Hans-Jürgen Gross; Alexa Bierlich; Katrin Dreissiger; Steffen Mannuß; Gabriele Siegert; Maximilian Bachem; Peter Kohlschein
Journal:  Br J Haematol       Date:  2013-06-29       Impact factor: 6.998

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.